Trial
NCT00736385
Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Duke University
Collaborators
—
Condition
Fatty Liver
Intervention
Glucophage (Metformin)
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-26